Evidence map›Paper›PMID 35822105›Full record

ArticleCommunications medicine2022

Comparative analyses of eighteen rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation.

Chad R Wells, Abhishek Pandey, Seyed M Moghadas, Burton H Singer, Gary Krieger, Richard J L Heron, David E Turner, Justin P Abshire, Kimberly M Phillips, A Michael Donoghue and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Chad R WellsCenter for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT USA.ORCID 0000-0003-1370-8350
Abhishek PandeyCenter for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT USA.ORCID 0000-0003-4578-7487
Seyed M MoghadasAgent-Based Modelling Laboratory, York University, Toronto, ON Canada.ORCID 0000-0003-4414-0227
Burton H SingerEmerging Pathogens Institute, University of Florida, Gainesville, FL USA.
Gary KriegerNewFields E&E, Boulder, CO USA.
Richard J L HeronBP Plc, 1 ST James's Square, London, UK.
David E TurnerBP America Inc, Houston, TX USA.
Justin P AbshireHSE Specialties, BHP Petroleum, Houston, TX USA.
Kimberly M PhillipsBHP Petroleum, Houston, TX USA.ORCID 0000-0002-4728-9281
A Michael DonoghueGroup HSE, BHP Group Ltd, Melbourne, VIC Australia.ORCID 0000-0002-7999-0582
Alison P GalvaniCenter for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT USA.ORCID 0000-0002-2059-6716
Jeffrey P TownsendDepartment of Biostatistics, Yale School of Public Health, New Haven, CT USA.ORCID 0000-0002-9890-3907
Yale University · USBP (United States) · USBHP (Australia) · AUBP (United Kingdom) · GBUniversity of Colorado Boulder · USUniversity of Florida · USYork University · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) OV4 - 170643, COVID-19 RAPID RESEARCH
6 · The paper itself

Abstract

Background: Rapid antigen (RA) tests are being increasingly employed to detect SARS-CoV-2 infections in quarantine and surveillance. Prior research has focused on RT-PCR testing, a single RA test, or generic diagnostic characteristics of RA tests in assessing testing strategies. Methods: We have conducted a comparative analysis of the post-quarantine transmission, the effective reproduction number during serial testing, and the false-positive rates for 18 RA tests with emergency use authorization from The United States Food and Drug Administration and an RT-PCR test. To quantify the extent of transmission, we developed an analytical mathematical framework informed by COVID-19 infectiousness, test specificity, and temporal diagnostic sensitivity data. Results: We demonstrate that the relative effectiveness of RA tests and RT-PCR testing in reducing post-quarantine transmission depends on the quarantine duration and the turnaround time of testing results. For quarantines of two days or shorter, conducting a RA test on exit from quarantine reduces onward transmission more than a single RT-PCR test (with a 24-h delay) conducted upon exit. Applied to a complementary approach of performing serial testing at a specified frequency paired with isolation of positives, we have shown that RA tests outperform RT-PCR with a 24-h delay. The results from our modeling framework are consistent with quarantine and serial testing data collected from a remote industry setting. Conclusions: These RA test-specific results are an important component of the tool set for policy decision-making, and demonstrate that judicious selection of an appropriate RA test can supply a viable alternative to RT-PCR in efforts to control the spread of disease.

Indexed as

EpidemiologyInfectious diseasesPopulation screening

Identifiers

PMID35822105
PMCPMC9271059
OpenAlexW4284965281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.